View Document Preview and Link Document Date: 2013-04-09 10:59:32 Open Document File Size: 1.004,80 KB Share Result on Facebook
City Iselin / New York / Leuven / Brussels / / Company Producell Biotech NV / Patcobel NV / ThromboGenics Ltd / Novartis / NuVue / Alcon / Genentech / III MIVI Trust / Crossroads Databank / Bio-Incubator NV / Thromb-X NV / ThromboGenics NV / AMD / Philips / Grifols / East Hill Biopharmaceutical Partners / ThromboGenics Inc. / General ThromboGenics NV / / Continent Europe / / Country Norway / Belgium / United States / / Currency USD / EUR / / / Event FDA Phase / Funding / Company Expansion / Product Release / Business Partnership / / Facility University of Leuven / Flanders Institute / UK’s National Institute / / / IndustryTerm integrated biopharmaceutical / finance / treatment for patients with sight threatening ophthalmic disorders / imaging / biopharmaceutical / / MedicalCondition macular edema / retinal detachment / sight threatening ophthalmic disorders / blindness / acute myocardial infarction / macular hole / diabetic retinopathy / cancer / disease / chronic / myocardial infarction / irritation / eye disease / inflammation / cataract / retinal tear / / MedicalTreatment Gene therapy / thrombolytic therapy / / MusicGroup Board of Directors / / Organization Center for Transgene Technology and Gene / Center for Molecular and Vascular Biology of the KULeuven / Medicare / Center for Molecular / European Medicines Agency / European Commission / FDA / European Union / National Health Service / Institute for Health / / Person Patricia Ceysens / Luc Philips / Gaston Geenslaan / Jean-Luc Dehaene / Staf Van Reet / Désiré Collen / / / Position counsel / General / Founder / CEO / Chairman / Professor / director / Major / / Product JETREA / Annual Report / JETREA® (ocriplasmin) / / ProvinceOrState New Jersey / / Technology Biotechnology / Gene therapy / / URL www.thrombogenics.com / thrombogenics.com / / SocialTag 
Financial information 2012 Content